LACTOSE (INDIA)
Back to Cashflow Statement
|
LACTOSE (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-0.29 Cr | ₹8.75 Cr | ₹7.89 Cr | ₹8.47 Cr | ₹2.17 Cr |
What is the latest Cash Flow from Operating Activities ratio of LACTOSE (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-0.29 Cr |
| Mar2024 | ₹8.75 Cr |
| Mar2023 | ₹7.89 Cr |
| Mar2022 | ₹8.47 Cr |
| Mar2021 | ₹2.17 Cr |
How is Cash Flow from Operating Activities of LACTOSE (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.29 Cr | Negative | |
| Mar2024 | ₹8.75 Cr | 10.79 | |
| Mar2023 | ₹7.89 Cr | -6.78 | |
| Mar2022 | ₹8.47 Cr | 291.09 | |
| Mar2021 | ₹2.17 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹129.8 Cr | -1% | -4.9% | 1.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | 0.5% | 4.6% | 11.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,179.0 Cr | -0.6% | 2.2% | -0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.2% | 8.1% | 43.9% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.1% | 5.6% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | -0.3% | 5.6% | -0.1% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -1% |
-4.9% |
1.1% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses